MedPath

Adolescent Projections During Transition in Prader-Willi Syndrome

Not Applicable
Not yet recruiting
Conditions
Prader-Willi Syndrome
Registration Number
NCT06279052
Lead Sponsor
University Hospital, Toulouse
Brief Summary

Single-center, cross-sectional qualitative study seeking to collect the experience of adolescence and the transition to adulthood of people affected by Prader-Willi syndrome in a population. To do this, the present will carry out a qualitative study with a reflexive thematic analysis of the data collected through semi-structured interviews using an interview guide.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Patients with genetically confirmed Prader-Willi syndrome
  • Patients affiliated or beneficiaries of a social security system
  • Patients known and followed by the reference center, presenting sufficient intellectual skills to answer the interview questions
Exclusion Criteria
  • Refusal of family participation (if minor)
  • Refusal of participation by the patient or his guardian (if of legal age)

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Experience of the disease and aspirations regarding the future1 hour

The main objective of this study is to explore their experience of the disease and their aspirations regarding their future in a population of older adolescents and young adults with Prader-Willi syndrome. A questionnaire created by the clinical investigator containing personal questions will be applied to all patients. There is no scale.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CHU de Toulouse

🇫🇷

Toulouse, France

CHU de Toulouse
🇫🇷Toulouse, France
Grégoire BENVEGNU
Contact
benvegnu.g@chu-toulouse.fr
Dalil Benkanoun
Contact
dalil.benkanoun@hotmail.fr

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.